Potential Uses of Probiotics in Clinical Practice

Clinical Microbiology Reviews

Volumn 16, Issue 4, 2003, Pages 658-672

  Reid, Gregor ^a,b   Jass, Jana ^a,b   Sebulsky, M Tom ^b   McCormick, John K ^a,b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ALLERGY; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CLINICAL PRACTICE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ENTERITIS; GASTROENTERITIS; HUMAN; INFLAMMATORY DISEASE; INTERNATIONAL COOPERATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MEDICAL RESEARCH; MUCOSAL IMMUNITY; NEOPLASM; NONHUMAN; ORAL REHYDRATION THERAPY; ORGANIZATION; PATIENT CARE; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PROPHYLAXIS; PROPIONIBACTERIUM; REVIEW; UROGENITAL TRACT INFECTION; WORLD HEALTH ORGANIZATION;

ADULT; CHILD, PRESCHOOL; CLINICAL TRIALS; DIARRHEA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INFECTION; LACTOBACILLUS; PROBIOTICS;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM BV. INFANTIS; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; POSIBACTERIA; PROPIONIBACTERIUM;

EID: 0142095003     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.16.4.658-672.2003     Document Type: Review

References (155)

1. Adams, M. R., and P. Marteau. 1995. On the safety of lactic acid bacteria from food. Int. J. Food Microbiol. 27:263-264.
2. Aiba, Y., N. Suzuki, A. M. Kabir, A. Takagi, and Y. Koga. 1998, Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol. 93:2097-2101.
3. Arimochi, H., T. Kinouchi, K. Kataoka, T. Kuwahara, and Y. Ohnishi. 1997. Effect of intestinal bacteria on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochem. Biophys. Res. Commun. 238:753-757.
4. Arunachalam, K., H. S. Gill, and R. K. Chandra. 2000. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur. J. Clin. Nutr. 54:263-267.
5. Aso, Y., H. Akaza, T. Kotake, T. Tsukamoto, K. Imai, and S. Naito. 1995. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur. Urol. 27:104-109.
6. Barbes, C., and S. Boris. 1999. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care STDs 13:747-751.
7. Bartlett, J. G. 2002. Clinical practice. Antibiotic-associated diarrhea. N. Engl. J. Med. 346:334-339.
8. Beaugerie, L., A. Flahault, F. Barbut, P. Atlan, V. Lalande, P. Cousin, M. Cadilhac, and J. C. Petit. 2003. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol. Ther. 17:905-912.
9. Behets, F., J. Andriamiadana, D. Rasamilalao, N. Ratsimbazafy, D. Randrianasolo, G. Dallabetta, and M. Cohen. 2001. Sexually transmitted infections and associated socio-demographic and behavioural factors in women seeking primary care suggest Madagascar's vulnerability to rapid HIV spread. Trop. Med. Int. Health 6:202-211.
10. Benn, C. S., P. Thorsen, J. S. Jensen, B. B. Kjaer, H. Bisgaard, M. Andersen, K. Rostgaard, B. Bjorksten, and M. Melbye. 2002. Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J. Allergy Clin. Immunol. 110:72-77.
11. Bernet, M. F., D. Brassart, J. R. Neeser, and A. L. Servin. 1994. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35:483-489.
12. Bernet-Camard, M. F., V. Lievin, D. Brassart, J. R. Neeser, A. L. Servin, and S. Hudault. 1997. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63:2747-2753.
13. Blakey, J. L., L. Lubitz, N. T. Campbell, G. L. Gillam, R. F. Bishop, and G. L. Barnes. 1985. Enteric colonization in sporadic neonatal necrotizing enterocolitis. J. Pediatr. Gastroenterol. Nutr. 4:591-595.
14. Brumfitt, W., and J. M. Hamilton-Miller. 1998. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years experience. J. Antimicrob. Chemother. 42:363-371.
15. Brumfitt, W., J. M. Hamilton-Miller, R. A. Gargan, J. Cooper, and G. W. Smith. 1983. Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine. J. Urol. 130:1110-1114.
16. Brumfitt, W., J. M. Hamilton-Miller, S. Walker, and D. Roberts. 1992. Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin. Drugs Exp. Clin. Res. 18:239-244.
17. Burton, J. P., P. A. Cadieux, and G. Reid. 2003. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl. Environ. Microbiol. 69:97-101.
18. Cadieux, P., J. Burton, G. Gardiner, I. Braunstein, A. W. Bruce, C. Y. Kang, and G. Reid. 2002. Lactobacillus strains and vaginal ecology. JAMA 287:1940-1941.
19. Canducci, F., A. Armuzzi, F. Cremonini, G. Cammarota, F. Bartolozzi, P. Pola, G. Gasbarrini, and A. Gasbarrini. 2000. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol. Ther. 14:1625-1629.
20. Caplan, M. S., and T. Jilling. 2000. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J. Pediatr. Gastroenterol. Nutr. 30(Suppl. 2):S18-S22.
21. Castagliuolo, I., M. F. Riegler, L. Valenick, J. T. LaMont, and C. Pothoulakis. 1999. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 67:302-307.
22. Challa, A., D. R. Rao, C. B. Chawan, and L. Shackelford. 1997. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18:517-521.
23. Christensen, H. R., H. Frokiaer, and J. J. Pestka. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168:171-178.
24. Coconnier, M. H., M. F. Bernet, S. Kerneis, G. Chauviere, J. Fourniat, and A. L. Servin. 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett. 110:299-305.
25. Coconnier, M. H., V. Lievin, M. F. Bernet-Camard, S. Hudault, and A. L. Servin. 1997. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother. 41:1046-1052.
26. Coconnier, M. H., V. Lievin, E. Hemery, and A. L. Servin. 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64:4573-4580.
27. Cohen, C. R., A. Duerr, N. Pruithithada, S. Rugpao, S. Hillier, P. Garcia, and K. Nelson. 1995. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 9:1093-1097.
28. Conway, P. L., S. L. Gorbach, and B. R. Goldin. 1987. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 70:1-12.
29. Culhane, J. F., V. Rauh, K. F. McCollum, V. K. Hogan, K. Agnew, and P. D. Wadhwa. 2001. Maternal stress is associated with bacterial vaginosis in human pregnancy. Matern. Child Health J. 5:127-134.
30. Dani, C., R. Biadaioli, G. Bertini, E. Martelli, and F. F. Rubaltelli. 2002. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol. Neonate 82:103-108.
31. Darouiche, R. O., W. H. Donovan, M. Del Terzo, J. I. Thornby, D. C. Rudy, and R. A. Hull. 2001. Pilot trial of bacterial interference for preventing urinary tract infection. Urology 58:339-344.
32. Delaney, M. L., and A. B. Onderdonk. 2001. Nugent score related to vaginal culture in pregnant women. Obstet. Gynecol. 98:79-84.
33. D'Souza, A. L., C. Rajkumar, J. Cooke, and C. J. Bulpitt. 2002. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br. Med. J. 324:1361.
34. Edmunds, L. 2001. The underuse of probiotics by family physicians. Can. Med. Assoc. J. 164:1577.
35. El-Nezami, H., H. Mykkanen, P. Kankaanpaa, S. Salminen, and J. Ahokas. 2000. Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum. J. Food Prot. 63:549-552.
36. Felley, C. P., I. Corthesy-Theulaz, J. L. Rivero, P. Sipponen, M. Kaufmann, P. Bauerfeind, P. H. Wiesel, D. Brassart, A. Pfeifer, A. L. Blum, and P. Michetti. 2001. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur. J. Gastroenterol. Hepatol. 13:25-29.
37. Food and Agriculture Organization of the United Nations and World Health Organization. 2002, posting date. Guidelines for the evaluation of probiotics in food. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report. (Online.)
38. Food and Agriculture Organization of the United Nations and World Health Organization. 2001, posting date. Regulatory and clinical aspects of dairy probiotics. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. Food and Agriculture Organization of the United Nations and World Health Organization Working Group Report. (Online.)
39. Franz, C. M., W. H. Holzapfel, and M. E. Stiles. 1999. Enterococci at the crossroads of food safety? Int. J. Food Microbiol. 47:1-24.
40. Gan, B. S., J. Kim, G. Reid, P. Cadieux, and J. C. Howard. 2002. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185:1369-1372.
41. Gardiner, D., S. Murphey, E. Ossman, and D. Jungkind. 2002. Prevalence and acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Infect. Control Hosp. Epidemiol. 23:466-468.
42. Gardiner, G., C. Heinemann, M. Baroja, A. Bruce, D. Beuerman, J. Madrenas, and G. Reid. 2002. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int. Dairy J. 12:191-196.
43. Gardiner, G. E., C. Heinemann, A. W. Bruce, D. Beuerman, and G. Reid. 2002. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Immunol. 9:92-96.
44. Gewolb, I. H., R. S. Schwalbe, V. L. Taciak, T. S. Harrison, and P. Panigrahi. 1999. Stool microflora in extremely low birthweight infants. Arch. Dis. Child. Fetal Neonatal 80:F167-F173.
45. Gill, H. S., K. J. Rutherfurd, J. Prasad, and P. K. Gopal. 2000. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J. Nutr. 83:167-176.
46. Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119:305-309.
47. Glass, R. I., J. F. Lew, R. E. Gangarosa, C. W. LeBaron, and M. S. Ho. 1991. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J. Pediatr. 118:S27-33.
48. Gopal, P. K., J. Prasad, J. Smart, and H. S. Gill. 2001. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 67:207-216.
49. Gorbach, S. L. 2000. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 95:S2-4.
50. Guandalini, S. 2002. Use of Lactobacillus-GG in paediatric Crohns disease. Dig. Liver Dis. 34(Suppl. 2):S63-S65.
51. Guandalini, S., L. Pensabene, M. A. Zikri, J. A. Dias, L. G. Casali, H. Hoekstra, S. Kolacek, K. Massar, D. Micetic-Turk, A. Papadopoulou, J. S. de Sousa, B. Sandhu, H. Szajewska, and Z. Weizman. 2000. Lactobacillus sp. strain GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30:54-60.
52. Guarino, A., R. B. Canani, M. I. Spagnuolo, F. Albano, and L. Di Benedetto. 1997. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 25:516-519.
53. Hamer, D. H., and C. J. Gill. 2002. From the farm to the kitchen table: the negative impact of antimicrobial use in animals on humans. Nutr. Rev. 60:261-264.
54. Hay, P. 2000. Recurrent bacterial vaginosis. Curr. Infect. Dis. Rep. 2:506-512.
55. Hennequin, C., C. Kauffmann-Lacroix, A. Jobert, J. P. Viard, C. Ricour, J. L. Jacquemin, and P. Berche. 2000. Possible role of catheters in Saccharomyces boulardii fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 19:16-20.
56. Hillier, S. L. 1998. The vaginal microbial ecosystem and resistance to HIV. AIDS Res. Hum. Retroviruses 14(Suppl. 1):S17-S21.
57. Hosoda, M., H. Hashimoto, F. He, H. Morita, and A. Hosono. 1996. Effect of administration of milk fermented with Lactobacillus acidophilus LA-2 on fecal mutagenicity and microflora in the human intestine. J. Dairy Sci. 79:745-749.
58. Hoyos, A. B. 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Infect. Dis. 3:197-202.
59. Hudault, S., V. Lievin, M. F. Bernet-Camard, and A. L. Servin. 1997. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 63:513-518.
60. Hughes, V. L., and S. L. Hillier. 1990. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet. Gynecol. 75:244-248.
61. Isolauri, E., T. Arvola, Y. Sutas, E. Moilanen, and S. Salminen. 2000. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30:1604-1610.
62. Isolauri, E., M. Juntunen, T. Rautanen, P. Sillanaukee, and T. Koivula. 1991. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88:90-97.
63. Isolauri, E., Y. Sutas, P. Kankaanpaa, H. Arvilommi, and S. Salminen. 2001. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73:444S-450S.
64. Kabir, A. M., Y. Aiba, A. Takagi, S. Kamiya, T. Miwa, and Y. Koga. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41:49-55.
65. Kaila, M., E. Isolauri, E. Soppi, E. Virtanen, S. Laine, and H. Arvilommi. 1992. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32:141-144.
66. Kalliomaki, M., S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076-1079.
67. Kalliomaki, M., S. Salminen, T. Poussa, H. Arvilommi, and E. Isolauri. 2003. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869-1871.
68. Keane, F. E., C. A. Ison, and D. Taylor-Robinson. 1997. A longitudinal study of the vaginal flora over a menstrual cycle. Int. J. STDs AIDS 8:489-494.
69. Kollaritsch, H., H. Holst, P. Grobara, and G. Wiedermann. 1993. Prevention of travelers diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschr. Med. 111:152-156.
70. Kullen, M. J., and T. R. Klaenhammer. 1999. Identification of the pH-inducible, proton-translocating F1F0-ATPase (atpBEFHAGDC) operon of Lactobacillus acidophilus by differential display: gene structure, cloning and characterization. Mol Microbiol. 33:1152-1161.
71. Lewis, S. J., L. F. Potts, and R. E. Barry. 1998. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J. Infect. 36:171-174.
72. Livengood, C. H., 3rd, D. E. Soper, K. L. Sheehan, D. E. Fenner, M. G. Martens, A. L. Nelson, M. Ismail, J. M. Thorp, M. Lappin, B. J. Long, T. Blackwelder, R. L. Sweet, and S. Sagov. 1999. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex. Transm. Dis. 26:137-142.
73. Lucas, A., and T. J. Cole. 1990. Breast milk and neonatal necrotising enterocolitis. Lancet 336:1519-1523.
74. Lundgren, O., and L. Svensson. 2001. Pathogenesis of rotavirus diarrhea. Microbes Infect. 3:1145-1156.
75. Maassen, C. B., C. van Holten-Neelen, F. Balk, M. J. den Bak-Glashouwer, R. J. Leer, J. D. Laman, W. J. Boersma, and E. Claassen. 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613-2623.
76. MacDermott, R. P. 1996. Alterations of the mucosal immune system in inflammatory bowel disease. J. Gastroenterol. 31:907-916.
77. Mack, D. R., S. Michail, S. Wei, L. McDougall, and M. A. Hollingsworth. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276:G941-G950.
78. Mackie, R. I., A. Sghir, and H. R. Gaskins. 1999. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69:1035S-1045S.
79. Madden, J. A., and J. O. Hunter. 2002. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br. J. Nutr. 88(Suppl. 1):S67-S72.
80. Majamaa, H., and E. Isolauri. 1996. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J. Allergy Clin. Immunol. 97:985-990.
81. Majamaa, H., E. Isolauri, M. Saxelin, and T. Vesikari. 1995. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 20:333-338.
82. Marteau, P. R. 2002. Probiotics in clinical conditions. Clin. Rev. Allergy Immunol. 22:255-273.
83. Martin, H. L., B. A. Richardson, P. M. Nyange, L. Lavreys, S. L. Hillier, B. Chohan, K. Mandaliya, J. O. Ndinya-Achola, J. Bwayo, and J. Kreiss. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180:1863-1868.
84. Matsuzaki, T., and J. Chin. 2000. Modulating immune responses with probiotic bacteria. Immunol. Cell Biol. 78:67-73.
85. McFarland, L. V., and G. W. Elmer. 1995. Biotherapeutic agents: past, present and future. Microecol. Ther. 23:46-73.
86. McFarland, L. V., C. M. Surawicz, R. N. Greenberg, G. W. Elmer, K. A. Moyer, S. A. Melcher, K. E. Bowen, and J. L. Cox. 1995. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 90:439-448.
87. McGroarty, J. A., G. Reid, and A. W. Bruce. 1994. The influence of nonoxynol-9-containing spermicides on urogenital infection. J. Urol. 152:831-833.
88. Michetti, P., G. Dorta, P. H. Wiesel, D. Brassart, E. Verdu, M. Herranz, C. Felley, N. Porta, M. Rouvet, A. L. Blum, and I. Corthesy-Theulaz. 1999. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) Lal on Helicobacter pylori infection in humans. Digestion 60:203-209.
89. Midolo, P. D., J. R. Lambert, R. Hull, F. Luo, and M. L. Grayson. 1995. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol. 79:475-479.
90. Miettinen, M., A. Lehtonen, I. Julkunen, and S. Matikainen. 2000. Lactobacilli and streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol. 164:3733-3740.
91. Millar, M. R., C. Bacon, S. L. Smith, V. Walker, and M. A. Hall. 1993. Enteral feeding of premature infants with Lactobacillus sp. strain GG. Arch. Dis. Child. 69:483-487.
92. Mitsuyama, K., A. Toyonaga, and M. Sata. 2002. Intestinal microflora as a therapeutic target in inflammatory bowel disease. J. Gastroenterol. 37(Suppl. 14):73-77.
93. Naidu, A. S., W. R. Bidlack, and R. A. Clemens. 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit. Rev. Food Sci. Nutr. 39:13-126.
94. Niedzielin, K., H. Kordecki, and B. Birkenfeld. 2001. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 13:1143-1147.
95. Nugent, R. P., M. A. Krohn, and S. L. Hillier. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29:297-301.
96. Oatley, J. T., M. D. Rarick, G. E. Ji, and J. E. Linz. 2000. Binding of aflatoxin B1 to bifidobacteria in vitro. J. Food Prot. 63:1133-1136.
97. Oberhelman, R. A., R. H. Gilman, P. Sheen, D. N. Taylor, R. E. Black, L. Cabrera, A. G. Lescano, R. Meza, and G. Madico. 1999. A placebo-controlled trial of Lactobacillus sp. strain GG to prevent diarrhea in undernourished Peruvian children. J. Pediatr. 134:15-20.
98. 2-generating Lactobacillus species for probiotic use. Curr. Microbiol. 38:279-284.
99. Olah, A., T. Belagyi, A. Issekutz, M. E. Gamal, and S. Bengmark. 2002. Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br. J. Surg. 89:1103-1107.
100. Perdigon, G., S. Alvarez, and A. Pesce de Ruiz Holgado. 1991. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J. Dairy Res. 58:485-496.
101. Perdigon, G., and A. P. d. R. Holgado. 2000. Mechanisms involved in the immunostimulation by lactic acid bacteria., p. 213-233. In R. Fuller and G. Perdigon (ed.), Probiotics. Kluwer Academic Publishers, Amsterdam, The Netherlands.
102. Pochapin, M. 2000. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95:S11-S13.
103. Prantera, C., M. L. Scribano, G. Falasco, A. Andreoli, and C. Luzi. 2002. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohns disease: a randomised controlled trial with Lactobacillus sp. strain GG. Gut 51:405-409.
104. Rautio, M., H. Jousimies-Somer, H. Kauma, I. Pietarinen, M. Saxelin, S. Tynkkynen, and M. Koskela. 1999. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis. 28:1159-1160.
105. Rayes, N., S. Hansen, D. Seehofer, A. R. Muller, S. Serke, S. Bengmark, and P. Neuhaus, 2002. Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18:609-615.
106. Rayes, N., D. Seehofer, S. Hansen, K. Boucsein, A. R. Muller, S. Serke, S. Bengmark, and P. Neuhaus. 2002. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74:123-127.
107. Reid, G. 2000. In vitro analysis of a dairy strain of Lactobacillus acidophilus NCFMTM as a possible probiotic for the urogenital tract. Int. Dairy J. 10:415-419.
108. Reid, G. 2002. Safety of Lactobacillus strains as probiotic agents. Clin. Infect. Dis. 35:349-350.
109. Reid, G., A. W. Bruce, and M. Taylor. 1995. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol. Ther. 23:32-45.
110. Reid, G., D. Beuerman, C. Heinemann, and A. W. Bruce. 2001. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immuno. Med. Microbiol. 32:37-41.
111. Reference deleted.
112. Reid, G., and A. W. Bruce. 2001. Selection of Lactobacillus strains for urogenital probiotic applications. J. Infect. Dis. 183(Suppl. 1):S77-S80.
113. Reid, G., A. W. Bruce, N. Fraser, C. Heinemann, J. Owen, and B. Henning. 2001. Oral probiotics can resolve urogenital infections. FEMS Immunol. Med. Microbiol. 30:49-52.
114. Reference deleted.
115. Reid, G., D. Charbonneau, J. Erb, B. Kochanowski, D. Beuerman, R. Poehner, and A. W. Bruce. 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35:131-134.
116. Reid, G., D. Charbonneau, S. Gonzalez, G. Gardiner, J. Erb, and A. W. Bruce. 2002. Ability of Lactobacillus GR-1 and RC-14 to stimulate host defences and reduce gut translocation and infectivity of Salmonella typhimurium. Nutraceut. Food 7:168-173.
117. Reid, G., R. L. Cook, and A. W. Bruce. 1987. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J. Urol. 138:330-335.
118. Reid, G., J. A. McGroarty, L. Tomeczek, and A. W. Bruce. 1996. Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women. FEMS Immunol. Med. Microbiol. 15:23-26.
119. Reid, G., K. Millsap, and A. W. Bruce. 1994. Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet 344:1229.
120. Reid, G., C. Zalai, and G. Gardiner. 2001. Urogenital lactobacilli probiotics, reliability and regulatory issues. J. Dairy Sci. 84:E164-E169.
121. Reference deleted.
122. Reveneau, N., M. C. Geoffroy, C. Locht, P. Chagnaud, and A. Mercenier. 2002. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20:1769-1777.
123. Saavedra, J. M., N. A. Bauman, I. Oung, J. A. Perman, and R. H. Yolken. 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046-1049.
124. Sanders, M. E., L. Morelli, and S. Bush. 2001. "Lactobacillus sporogenes" is not a Lactobacillus probiotic. ASM News 67:385-386.
125. Scientific Committee on Animal Nutrition. 2001. Report of the Scientific Committee on Animal Nutrition on the criteria for assessing the safety of microorganisms resistant to antibiotics of human clinical and veterinary importance. European Commission Health and Consumer Protection Directorate-General.
126. Schwebke, J. R., C. M. Richey, and H. L. Weiss. 1999. Correlation of behaviors with microbiological changes in vaginal flora. J. Infect. Dis. 180:1632-1636.
127. Sen, S., M. M. Mullan, T. J. Parker, J. T. Woolner, S. A. Tarry, and J. O. Hunter. 2002. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig. Dis. Sci. 47:2615-2620.
128. Sewankambo, N., R. H. Gray, M. J. Wawer, L. Paxton, D. McNaim, F. Wabwire-Mangen, D. Serwadda, C. Li, N. Kiwanuka, S. L. Hillier, L. Rabe, C. A. Gaydos, T. C. Quinn, and J. Konde-Lule. 1997. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350:546-550.
129. Reference deleted.
130. Shanahan, F. 2000. Immunology. Therapeutic manipulation of gut flora. Science 289:1311-1312.
131. Sheih, Y. H., B. L. Chiang, L. H. Wang, C. K. Liao, and H. S. Gill. 2001. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr. 20:149-156.
132. Shornikova, A. V., I. A. Casas, E. Isolauri, H. Mykkanen, and T. Vesikari. 1997. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr. 24:399-404.
133. Shornikova, A. V., I. A. Casas, H. Mykkanen, E. Salo, and T. Vesikari. 1997. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 16:1103-1107.
134. Shu, Q., and H. Gill. 2002. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 34:59.
135. Sipsas, N. V., D. I. Zonios, and T. Kordossis. 2002. Safety of Lactobacillus strains used as probiotic agents. Clin. Infect. Dis. 34:1283-1285.
136. Skerman, V. B. D., V. McGowan, and P. H. A. Sneath. 1980. Approved lists of bacterial names. Int. J. Syst. Bacteriol. 30:225-420.
137. Souza, D. G., R. Guabiraba, V. Pinho, A. Bristow, S. Poole, and M. M. Teixeira. 2003. IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J. Immunol. 170:4759-4766.
138. Surawicz, C. M., G. W. Elmer, P. Speelman, L. V. McFarland, J. Chinn, and G. van Belle. 1989. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96:981-988.
139. Surawicz, C. M., L. V. McFarland, R. N. Greenberg, M. Rubin, R. Fekety, M. E. Mulligan, R. J. Garcia, S. Brandmarker, K. Bowen, D. Borjal, and G. W. Elmer. 2000. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 31:1012-1017.
140. Szajewska, H., M. Kotowska, J. Z. Mrukowicz, M. Armanska, and W. Mikolajczyk. 2001. Efficacy of Lactobacillus sp. strain GG in prevention of nosocomial diarrhea in infants. J. Pediatr. 138:361-365.
141. Taha, T. E., R. H. Gray, N. I. Kumwenda, D. R. Hoover, L. A. Mtimavalye, G. N. Liomba, J. D. Chiphangwi, G. A. Dallabetta, and P. G. Miotti. 1999. HIV infection and disturbances of vaginal flora during pregnancy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 20:52-59.
142. Taba, T. E., D. R. Hoover, G. A. Dallabetta, N. I. Kumwenda, L. A. Mtimavalye, L. P. Yang, G. N. Liomba, R. L. Broadhead, J. D. Chiphangwi, and P. G. Miotti. 1998. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12:1699-1706.
143. Taranto, M. P., M. Medici, G. Perdigon, A. P. Ruiz Holgado, and G. F. Valdez. 2000. Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J. Dairy Sci. 83:401-403.
144. Taylor-Robinson, D., M. McCaffrey, J. Pitkin, and R. F. Lamont. 2002. Bacterial vaginosis in climacteric and menopausal women. Int. J. STDs AIDS 13:449-452.
145. Thomas, M. R., S. C. Litin, D. R. Osmon, A. P. Corr, A. L. Weaver, and C. M. Lohse. 2001. Lack of effect of Lactobacillus sp. strain GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin. Proc. 76:883-889.
146. Vasquez, A., T. Jakobsson, S. Ahrne, U. Forsum, and G. Molin. 2002. Vaginal Lactobacillus flora of healthy Swedish women. J. Clin. Microbiol. 40:2746-2749.
147. Vidal, K., A. Donnet-Hughes, and D. Granato. 2002. Lipoteichoic acids from Lactobacillus johnsonii strain Lal and Lactobacillus acidophilus strain La10 antagonize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect. Immun. 70:2057-2064.
148. Walker, W. A. 2000. Role of nutrients and bacterial colonization in the development of intestinal host defense. J. Pediatr. Gastroenterol. Nutr. 30(Suppl. 2):S2-S7.
149. Wang, J., C. Jenkins, R. I. Webb, and J. A. Fuerst. 2002. Isolation of Gemmata-like and Isosphaera-like planctomycete bacteria from soil and freshwater. Appl. Environ. Microbiol. 68:417-422.
150. Ward, L. A., B. I. Rosen, L. Yuan, and L. J. Saif. 1996. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J. Gen. Virol. 77:1431-1441.
151. Wendakoon, C. N., A. B. Thomson, and L. Ozimek. 2002. Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection. Digestion 65:16-20.
152. World Health Organization. 1995. The treatment of diarrhoea - a manual for physicians and other senior health workers. World Health Organization/CDR/95.3. World Health Organization, Geneva, Switzerland.
153. Xu, J., and W. Verstraete. 2001. Evaluation of nitric oxide production by lactobacilli. Appl. Microbiol. Biotechnol. 56:504-507.
154. Yolken, R. H., C. Ojeh, I. A. Khatri, U. Sajjan, and J. F. Forstner. 1994. Intestinal mucins inhibit rotavirus replication in an oligosaccharide-dependent manner. J. Infect. Dis. 169:1002-1006.
155. Zhong, W., K. Millsap, H. Bialkowska-Hobrzanska, and G. Reid. 1998. Differentiation of Lactobacillus species by molecular typing. Appl. Environ. Microbiol. 64:2418-2423.